LATEST NEWS   South China Sea Code of Conduct is not an instrument to resolve overlapping claims, but a framework to ensure the waters remain safe as a trade route — Mohamad | Ringgit likely to go below 4.00 vs US dollar in 2H2026 when more visibility emerges on Fed rate cuts -- AmBank chief economist | AmBank raised its 2025 GDP growth forecast to 4.9 pct from 4.6 pct, and sees 2026 growth at 4.5 pct, citing greater clarity from recent trade agreements | Misuse of Grok: Communications Ministry to re-examine eight-million-user threshold for social media licensing requirement - Fahmi | OPR likely to remain unchanged at 2.75 pct throughout 2026 -- AmBank chief economist | 

There are 820 news based on search keyword " commercial"

Airbus Expansion In Malaysia Offers Promising Avenue For Green Aviation

KUALA LUMPUR, Sept 18 (Bernama) -- Airbus’ focus on sustainability presents a promising avenue for Malaysia to contribute to the future of green aviation as the aircraft manufacturer is set to expand its operations and sourcing in Malaysia, said Malaysia’s Ambassador to France, Datuk Eldeen Husaini Mohd Hashim.

EIG’s MidOcean Raises Stake In Peru LNG To 35 Pct

KUALA LUMPUR, Sept 17 (Bernama) -- MidOcean Energy (MidOcean), a liquefied natural gas (LNG) company formed and managed by EIG, and Hunt Oil Company (Hunt) announced they have entered into a definitive agreement for MidOcean to acquire an additional 15 per cent interest in Peru LNG (PLNG) from Hunt.

MPOB Ramps Up R&D On Oil Palm Seedlings To Boost Oil Palm Production

KUALA LUMPUR, Sept 15 (Bernama) -- The Malaysian Palm Oil Board (MPOB) is intensifying its research and development (R&D) efforts to produce superior oil palm variants which could boost the nation’s oil palm productivity and output without expanding the plantation area.

ALPS Global Aims To Raise US$100 Mln Via Nasdaq IPO

By Durratul Ain Ahmad Fuad

KUALA LUMPUR, Sept 15 (Bernama) – Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims to raise US$100 million to fund its expansion, clinical studies, and manufacturing plant.